Kyle C. Molina

机构：Scripps Research Institute, Scripps Health, Scripps Mercy Hospital, Scripps Green Hospital, Scripps Clinic, University of Colorado Anschutz, University of Colorado Denver · ORCID：0000-0002-6764-5984

发表论文 81 篇 · 总被引 1042 次 · h-index 18

代表论文

• Real-world use of nirmatrelvir–ritonavir in outpatients with COVID-19 during the era of omicron variants including BA.4 and BA.5 in Colorado, USA: a retrospective cohort study (2023 · The Lancet Infectious Diseases · 被引 151)
• Eravacycline, the first four years: health outcomes and tolerability data for 19 hospitals in 5 U.S. regions from 2018 to 2022 (2023 · Microbiology Spectrum · 被引 38)
• Long-term evaluation of clinical success and safety of omadacycline in nontuberculous mycobacteria infections: a retrospective, multicenter cohort of real-world health outcomes (2023 · Antimicrobial Agents and Chemotherapy · 被引 37)
• Change in effectiveness of sotrovimab for preventing hospitalization and mortality for at-risk COVID-19 outpatients during an Omicron BA.1 and BA.1.1-predominant phase (2022 · International Journal of Infectious Diseases · 被引 30)
• Oritavancin as sequential therapy for Gram-positive bloodstream infections (2024 · BMC Infectious Diseases · 被引 24)
• Previous corticosteroid exposure associates with an increased Pneumocystis jirovecii pneumonia mortality among HIV-negative patients: a global research network with a follow-up multicenter case-control study (2023 · Therapeutic Advances in Infectious Disease · 被引 15)